Cargando…
Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary
In recent years, international academics recognized that quality-adjusted life-years (QALYs) may not always fully capture the benefits produced by an intervention, and considered incorporating additional elements of value into cost-effectiveness analysis (CEA). Examples of these elements are adheren...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613353/ https://www.ncbi.nlm.nih.gov/pubmed/37898809 http://dx.doi.org/10.1186/s12962-023-00490-4 |